Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Phase I Study of PF-07799933 (ARRY-440) as Monotherapy or in Combination in Participants With Advanced Solid Tumors
Clinical Trial Grant
Duke Scholars
Principal Investigator
April Kelly Scott Salama
Medicine, Medical Oncology
Awarded By
Pfizer, Inc.
Start Date
September 12, 2023
End Date
November 15, 2023
Awarded By
Pfizer, Inc.
Start Date
September 12, 2023
End Date
November 15, 2023
